Newamsterdam Pharma Stock Overlap Studies Parabolic SAR Extended

NAMS Stock   20.84  0.21  1.00%   
NewAmsterdam Pharma overlap studies tool provides the execution environment for running the Parabolic SAR Extended study and other technical functions against NewAmsterdam Pharma. NewAmsterdam Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Parabolic SAR Extended study function is designed to identify and follow existing trends. NewAmsterdam Pharma overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify the following input to run this model: Start Value, Offset on Reverse, AF Init Long, AF Long, AF Max Long, AF Init Short, AF Short, and AF Max Short.

Study
Start Value
Offset on Reverse
AF Init Long
AF Long
AF Max Long
AF Init Short
AF Short
AF Max Short
Execute Study
The output start index for this execution was one with a total number of output elements of sixty. The Extended Parabolic SAR indicator is used to determine the direction of NewAmsterdam Pharma's momentum and the point in time when it has higher than normal probability of directional change. It has more input parameters than standard Parabolic SAR indicator.

NewAmsterdam Pharma Technical Analysis Modules

Most technical analysis of NewAmsterdam Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NewAmsterdam from various momentum indicators to cycle indicators. When you analyze NewAmsterdam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About NewAmsterdam Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NewAmsterdam Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of NewAmsterdam Pharma based on widely used predictive technical indicators. In general, we focus on analyzing NewAmsterdam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NewAmsterdam Pharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NewAmsterdam Pharma's intrinsic value. In addition to deriving basic predictive indicators for NewAmsterdam Pharma, we also check how macroeconomic factors affect NewAmsterdam Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Graham Number13.0410.2
Receivables Turnover41.737.06
Hype
Prediction
LowEstimatedHigh
17.5521.1624.77
Details
Intrinsic
Valuation
LowRealHigh
19.2522.8626.47
Details
9 Analysts
Consensus
LowTargetHigh
22.9025.1627.93
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.63-0.54-0.46
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Cash Cows Idea
Cash Cows
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Business Services Idea
Business Services
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.